Intellipharmaceutics International Inc. (Nasdaq: IPCI) today announced the appointment of Andrew Patient as Chief Financial Officer (“CFO”), effective September 6 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE